Posocznica u ludzi, psów i kotów - etiologia i epidemiologia

• Autorzy: Kalwas-Sliwinska M.

Warianty tytułu

EN

Etiology and epidemiology of septicemia in humans, dogs and cats

• Języki publikacji: PL

Abstrakty

EN

Słowa kluczowe

PL

czlowiek; zwierzeta; psy; koty; choroby zwierzat; posocznica; etiologia; epidemiologia; smiertelnosc

• Wydawca: -
• Czasopismo: Życie Weterynaryjne
• Rocznik: 2014
• Tom: 89
• Numer: 07
• Opis fizyczny: s.572-577,tab.,bibliogr.

Twórcy

autor

Kalwas-Sliwinska M.

• Katedra Chorób Wewnętrznych Małych Zwierząt z Kliniką, Wydział Medycyny Weterynaryjnej, Szkoła Główna Gospodarstwa Wiejskiego, Warszawa

Bibliografia

• 1. Kirby R.: Patophysiology of systemic inflammatory response syndromes: septic shock. Proceedings of 11th InternationalVeterinary Emergency and Critical Care Symposium(IVECCS), 2004, 467–469.
• 2. Kruth S.: Endotoksemia. W: Choroby zakaźne psów i kotów (pod red. Green C.), Galaktyka 2010, s. 263–271.
• 3. Kubler A., Jaeschke R., Jankowski M.: Sepsa i wstrząs septyczny. W: Choroby wewnętrzne. Stan wiedzy na rok 2011(pod red. A. Szczeklika), Medycyna Praktyczna 2011, s.2250–2255.
• 4. Martin G:. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert RevAnti Infect Ther. 2012, 10, 701–706.
• 5. Vigano F.: Sindrome della riposta infiammatoria sistemica e sindrome da insufficienza d’organo multipola. W:Medicina d’urgenza e terapia intensiva del cane e del gatto.I edizione, Masson, 2003, s. 28–36.
• 6. Annane D., Bellissant E., Cavaillon J.M.: Septic shock. The Lancet 2005, 365, 63–78.
• 7. Hilpert J.: Surviving sepsis: current management of patients with severe sepsis or septic shock. Proceedings ofthe 8th European Veterinary Emergency and Critical CareSociety (EVECCS), 2009, s. 46–48.
• 8. Hinshaw L.B., Brake C.M.: The mechanism of endotoxin shock. J Oklahoma State Med Assoc. 1964, 57, 421–428.
• 9. Beutler B., Milsark I.W., Cerami A.C.: Passive immunization against cachectin/tumor necrosis factor protectsmice from lethal effect of endotoxin. Science 1985, 229,869–871.
• 10. Sorensen T.I., Nielsen G.G., Andersen P.K., Teasdale T.W.: Genetic and environmental influences on premature deathin adult adoptees. N Engl J Med. 1988, 318, 727–732.
• 11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitionsfor sepsis and organ failure and guidelines for the use ofinnovative therapies in sepsis. Crit Care Med. 1992, 20,864–874.
• 12. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., Cohen J., Opal S.M., Vincent J.L., Ramsay G.: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit. Care Med. 2003, 31, 1250–1256.
• 13. Howell M.D., Talmor D, Schuetz P., Hunziker S., Jones A.E., Shapiro N.I.: Proof of principle: the predisposition,infection, response, organ failure sepsis staging system.Crit. Care Med. 2011, 39, 322–327.
• 14. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., Sevransky J.E., Sprung C.L., DouglasI.S., Jaeschke R., Osborn T.M., Nunnally M.E., TownsendS.R., Reinhart K., Kleinpell R.M., Angus D.C., DeutschmanC.S., Machado F.R., Rubenfeld G.D., Webb S., BealeR.J., Vincent J.L., Moreno R.: Surviving Sepsis Campaign:international guidelines for management of severe sepsisand septic shock, 2012. Intensive Care Med. 2013, 39, 165–228.
• 15. Annane D., Aegerter P., Jars-Guincestre M.C., Guidet B.: Current epidemiology of septic shock: the CUB-Rea Network.Am J Respir Crit Care Med. 2003, 2, 165–172.
• 16. Martin G.S., Mannino D.M., Eaton S., Moss M.: The epidemiology of sepsis in the United States from 1979 through2000. N Engl J Med. 2003, 16, 1546–1554.
• 17. Danai P., Martin G.S.: Epidemiology of sepsis: recent advances. Curr Infect Dis Rep. 2005, 7, 329–334.
• 18. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J.R., PavenD.: Sepsis in European intensive care units: results of theSOAP study. Crit. Care Med. 2006, 34, 344–353.
• 19. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L.: Facing the challenge: decreasing case fatality rates in severesepsis despite increasing hospitalizations. Crit. CareMed. 2005, 11, 2555–2562.
• 20. Sundararajan V., Macisaac C.M., Presneill J.J., Cade J.F., Visvanathan K.: Epidemiology of sepsis in Victoria, Australia.Crit. Care Med. 2005, 1, 71–78.
• 21. Dombrovskiy V.Y., Martin A.A., Sunderram J., Paz H.L.: Rapid increase in hospitalization and mortality rates forsevere sepsis in the United States: a trend analysis from1993 to 2003. Crit. Care Med. 2007, 5, 1244–1250.
• 22. Finfer S., Bellomo R., Lipman J., French C., Dobb G., Myburgh J.: Adult-population incidence of severe sepsis inAustralian and New Zealand intensive care units. IntensiveCare Med. 2004, 4, 589–596.
• 23. Harrison D.A., Welch C.A., Eddleston J.M.: The epidemiology of severe sepsis in England, Wales and NorthernIreland, 1996 to 2004: secondary analysis of a high qualityclinical database, the ICNARC case mix programmedatabase. Crit. Care 2006, 10, R42.
• 24. Degoricija V., Sharma M., Legac A., Gradiser M., Sefer S., Vucicevic Z.: Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy. Croat. Med. J. 2006, 3, 385–397.
• 25. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., Sicignano A., Palazzo M., MorenoR., Boulme R., Lepage E., Le Gall R.: Epidemiology ofsepsis and infection in ICU patients from an internationalmulticentre cohort study. Intensive Care Med. 2002,2, 108–121.
• 26. Lin M.T., Albertson T.E. Genomic polymorphisms in sepsis. Crit Care Med. 2004, 2, 569–579.
• 27. Parrillo J.E., Parker M.M., Natanson C., Suffredini A.F., Danner R.L., Cunnion R.E., Ognibene F.P.: Septic shockin humans. Advances in the understanding of pathogenesis,cardiovascular dysfunction, and therapy. Ann InternMed. 1990, 3, 227–242.
• 28. Pittet D., Wenzel R.P.: Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995, 11, 1177–1184.
• 29. Trick W.E., Jarvis W.R.: Epidemiology of nosocomial fungal infection in the 1990s. Rev Iberoam Micol. 1998, 1, 2–6.
• 30. Greiner M., Wolf G., Hartmann K.: A retrospective study of the clinical presentation of 140 dogs and 39 cats with bacteraemia. J Small Anim Pract. 2008, 49, 378–383.
• 31. Costello M.: Feline state of affairs: review of the literature. Proceedings of 11th International Veterinary Emergency and Critical Care Symposium (IVECCS), 2005, 381–383.
• 32. De Lafocarde A.: Sepsis in the dog: review of the literature. Proceedings of 10th International Veterinary Emergency and Critical Care Symposium (IVECCS), 2004, s. 691–694.
• 33. Otto C.: Sepsis in veterinary patients: what can we do and where can we go? J Vet Emerg Crit Care 2007, 17(4), 329–332
• 34. Otto C.: A fresh look at identifying sepsis in cats. Veterinary Medicine 2010, 9, 416–422
• 35. Matthews K.: Sepsis/Septic shock. W: Veterinary Emergency and Critical Care Manual. Edit: Mathews K., A Lifelearn Publication, 2006, s. 588–596.
• 36. Costello M.: Sepsis in the cat. Proceedings of 10th International Veterinary Emergency and Critical Care Symposium(IVECCS), 2004, s. 707–711.
• 37. Kalwas-Śliwińska M.: Katastrofalne zapalenie. Część I. Jak postawić wstępne rozpoznanie posocznicy u kota?Mag Wet. 2013, 19, 1183–1187.
• 38. Nemzek J.A., Agrodnia M.D., Hauptman J.G.: Breed-specific pro-inflammatory cytokine production as a predisposingfactor for susceptibility to sepsis in the dog. J VetEmerg Crit Care 2007, 17, 368–372.
• 39. Dinarello C.A. Pro-inflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septicshock. Chest 1997, 12, 321–329.
• 40. Costello M.: Underlying cause, pathophysiologic abnormalities, and response to treatment in cats with septicperitonitis: 51 cases (1990–2001) J Am Vet Med Assoc2004, 225, 897–902.
• 41. Glickman L.T., Domanski L.M., Patronek G.J., Visintainer F.: Breed-related risk factors for canine parvovirus enteritis.J Am Vet Med Assoc 1985, 187, 589–594.
• 42. Dienstknecht T., Schwacha M.G., Kang S., Rue L.W., Bland K.I., Chaundry I.H.: Sex steroid-mediated regulationof macrophage/monocyte function in a two-hit modelof trauma-hemorrhage and sepsis. Cytokine 2004, 25,110–118.
• 43. Jarrar D., Wang P., Cioffi W.G., Bland K.I., Chaundry I.H.: The female reproductive cycle is an important variable in the response to trauma-hemorrhage. Am J Physiol Heart Circ Physiol 2000, 279, H1015-H1021.
• 44. Ghosh A., KuKanich K., Brown C., Zurek L.: Resident cats In small Animals veterinary hospitals carry multi-drug resistant enterococci and are likely involved In cross-contamination of the hospital environment. Frontiers in Microbiology,2012, 3, 1–14.
• 45. Waddell L. Risk factors, prognostic indicators, and outcome of pyothorax in cats. 80 cases (1986–1999). J AmVet Med Assoc. 2002, 221, 819–824.
• 46. Brady C.A., Otto C.M., Van Winkle T.J. Severe sepsis in cats: 29 cases (1986–1998). J Am Vet Med Assoc 2000,217, 531–535.
• 47. Dow S.W., Curtis C.R., Jones R.L., Wingfield W.E.: Bacterial cultures of blood from critically ill dogs and cats:100 cases (1985–1987). J Am Vet Med Assoc 1989, 195,113–117.
• 48. Hirsh D.C., Jang S.S., Biberstein E.L.: Blood culture of the canine patient. J Am Vet Med Assoc 1984, 184, 175–178.
• 49. Calvert C.A., Greene C.E., Hardie E.M.: Cardiovascular infections in dogs: epizootiology, clinical manifestations,and prognosis. J Am Vet Med Assoc 1885, 187, 612–616.
• 50. Brady C.A., Otto C.M.: Systemic inflammatory response syndrome, sepsis, and multiple organ dysfunction. VetClin North Am Small Anim Pract. 2001, 31(6), 1147–1162.
• 51. Kalwas-Śliwińska M. Posocznica i wstrząs septyczny. W: Chirurgia małych zwierząt. Tom I. Chirurgia ogolna.Anestezjologia. Skora I tkanki miękkie. Pod red: MarkaGalanty, PWRiL, 2013, s. 53–63.
• 52. Hardie E., Rawlings C., Calvert C.: Severe sepsis in selected small animal surgical patients. J Am An Hosp Assoc1986, 22: 33–41.
• 53. Bentley A.M., Otto C.M., Shofer F.S.: Comparison of dogs with septic peritonitis: 1988–1993 versus 1999–2003. JVet Emerg Crit Care 2007, 17(4), 391–398.
• 54. Mueller M., Ludwig L., Barton L. Use of closed-suction drains to treat generalized peritonitis in dogs and cats: 40 cases (1997–1999). J Am Vet Med Assoc 2001, 219, 789–794
• 55. Malik R., Bars V.R., Church D.B, Zahn A., Allan G.S., Martin P., Wigney D.I., Love D.N..: Vegetative endocarditis insix cats. J Feline Med Surg 1999, 1, 171–180.
• 56. Sykes J.E., Kittleson M.D., Pesavento P.A., Byrne B.A., Mac- Donald K.A., Chomel B.B.: Evaluation of the relationshipbetween causative organisms and clinical characteristicsof infective endocarditis in dogs: 71 cases (1992–2005). JAm Vet Med Assoc. 2006, 228, 1723–1734.
• 57. Chomel B.B., Wey A.C., Kasten R.W., Stacy B.A., Labelle P.: Fatal case of endocarditis associated with Bartonellahenselae Type I infection in a domestic cat. J Clin Microbiol2003, 41, 5337–5339.
• 58. Fransson B.A., Lagerstedt A., Bergstrom A., Hagman R., Park J.S., Chew B.P., Evans M.A., Ragle C.A.: C-reactiveprotein, tumor necrosis factor alpha, and interleukin-6 indogs with pyometra and SIRS. J Vet Emerg Crit Care 2007,17, 373–381.
• 59. King L.: Postoperative complications and prognostic indicators in dogs and cats with septic peritonitis: 23 cases (1989–1992). J Am Vet Med Assoc 1994, 204, 407–414.
• 60. Serrano S. Management of septic shock: where do we stand?. Proceedings of 11th European Veterinary Emergency and Critical Care Symposium (EVECCS), 2012, s. 13–17.